archive-ie.com » IE » N » NCPE.IE

Total: 381

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Latest Drugs | National Centre for Pharmacoeconomics - Part 8
    Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Bosentan Tracleer July 8 2014 Ambrisentan Volibris July 4 2014 Alemtuzumab Lemtrada July 1 2014 Trastuzumab emtansine Kadcyla July 1 2014 Dabrafenib Tafinlar July 1 2014 Regorafenib Stivarga for mCRC July 1 2014 Buprenorphine naloxone Suboxone June 30 2014 Teriflunomide Aubagio June 30 2014 Omalizumab Xolair June 25 2014 Dabigatran Etexilate Pradaxa for the treatment

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/8/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 9
    this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Empagliflozin Jardiance June 17 2014 Tadalafil Adcirca May 27 2014 Sildenafil Revatio May 23 2014 Riociguat Adempas May 20 2014 Brimonidine 3 3 mg g gel Mirvaso May 7 2014 Clindamycin 1 with tretinoin 0 025 Treclinac May 7 2014 Oladaterol Striverdi Respimat May 6 2014 Avanafil Spedra May 2 2014 Brentuximab vedotin Adcetris April 11 2014

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/9/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 10
    Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Nalmefene Selincro April 8 2014 Sodium Chloride 70mg ml Sodium Hyaluronate 1mg ml Hyaneb March 25 2014 Dolutegravir Tivicay March 13 2014 Abiraterone acetate Zytiga for mCRPC post ADT March 10 2014 Incobotulinum Toxin Type A Xeomin March 6 2014 Eltrombopag Revolade February 14 2014 Aflibercept Zaltrap February 12 2014 Macitentan Opsumit January 31 2014 Liquid Paraffin Ointment VitA

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/10/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 20
    Pharmacoeconomic Research ICORN Education Latest Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Collagenase Clostridium Histolyticum Xiapex June 9 2011 Exenatide Bydureon June 9 2011 Adalimumab Humira June 2 2011 Vernakalant Brinavess May 4 2011 Tapentadol Palexia April 13 2011 Paliperidone palmitate Xeplion April 9 2011 Tafluprost Saflutan April 9 2011 Retigabine Trobalt April 6 2011 Prucalopride Resolor March 29 2011 Bilastine Drynol

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/20/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 24
    Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Dabigatran Etexilate Pradaxa for the Primary Prevention of Venous Thromboembolic Events after Total Hip Knee Replacement September 11 2008 Melatonin Circadin August 14 2008 Nilotinib Tasigna CML resistant intolerant to imatinib February 29 2008 Lapatinib Tyverb January 28 2008 Sublingual Immunotherapy Grazax September 4 2007 Natalizumab Tysabri April 27 2007 Sunitinib Sutent November 9 2006

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/24/ (2015-10-30)
    Open archived version from archive

  • NCPE Ceritinib (Zykadia®) Assessment | National Centre for Pharmacoeconomics
    Drugs Vaccines Diagnostics and Other Technologies Publications Peer Reviewed Papers Abstracts Reports Research Drug Utilisation Research Pharmacoeconomic Research ICORN Education Ceritinib Zykadia In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Zykadia is indicated for the treatment of adult patients with ALK positive advanced NSCLC previously treated with crizotinib Rapid Review Commenced Completed Outcome 29 05 2015 22 07 2015 Full Pharmacoeconomic Evaluation Recommended at

    Original URL path: http://www.ncpe.ie/drugs/ceritinib-zykadia/ (2015-10-30)
    Open archived version from archive

  • NCPE Nivolumab (Opdivio®) Assessment | National Centre for Pharmacoeconomics
    Evaluations Drugs Vaccines Diagnostics and Other Technologies Publications Peer Reviewed Papers Abstracts Reports Research Drug Utilisation Research Pharmacoeconomic Research ICORN Education Nivolumab Opdivio for NSCLC In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Opdivio is indicated for the treatment of locally advanced or metastatic squamous NSCLC after prior chemotherapy in adults Rapid Review Commenced Completed Outcome 02 07 2015 16 07 2015 Full Pharmacoeconomic

    Original URL path: http://www.ncpe.ie/drugs/nivolumab-opdivio-for-nsclc/ (2015-10-30)
    Open archived version from archive

  • NCPE Nivolumab (Opdivio®) Assessment | National Centre for Pharmacoeconomics
    Templates Pharmacoeconomic Evaluations Drugs Vaccines Diagnostics and Other Technologies Publications Peer Reviewed Papers Abstracts Reports Research Drug Utilisation Research Pharmacoeconomic Research ICORN Education Nivolumab Opdivio for Melanoma In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Opdivio is indicated as for monotherapy treatment for patients diagnosed with unresectable metastatic melanoma Rapid Review Commenced Completed Outcome 28 05 2015 16 07 2015 Full Pharmacoeconomic Evaluation Recommended

    Original URL path: http://www.ncpe.ie/drugs/nivolumab-opdivio-for-melanoma/ (2015-10-30)
    Open archived version from archive